Part 2: Clinical Trials

3 trials of Part 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Completed 1

Follow Part 2: new trials by email Literature Review of Part 2 trials Research Report on Part 2

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
Part 1, Part 2 - Drug Interaction
Phase 1CompletedHarmony Biosciences Management, Inc.292025-06-062026-02-09
Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD
AERO-001, AERO-002, AERO-007 - COPD
Phase 1 / Phase 2CompletedAeroRx Therapeutics Inc.242025-01-152025-08-01
A Study in Patients With Advanced Breast Cancer
Part 1, Part 2, Part 3 - HER2-negative Breast Cancer, Advanced Breast Cancer
Phase 1TerminatedSun Pharma Advanced Research Company Limited92022-05-202023-05-22

Conditions studied

Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Aspiration (1)

Sponsors

AeroRx Therapeutics Inc. (1)  ·  Harmony Biosciences Management, Inc. (1)  ·  Sun Pharma Advanced Research Company Limited (1)

Countries

Australia (1)  ·  India (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Dave Singh, MD (1)  ·  Kristen Bzdek, MD (1)  ·  Thomas Polasek, MD, PhD (1)